MD Earnings & Financial Statements
Pediatrix Medical Group, Inc.
$26.25
+$0.42(+1.63%)
55
Overall
80
Value
30
Tech
55
Quality
Market Cap
$2.11B
Volume
132.51K
52W Range
$15.70 - $27.94
Target Price
$26.57
MD earnings and financial statements: Pediatrix Medical Group, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
MD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B |
| Cost of revenue | $1.42B | $1.56B | $1.57B | $1.50B | $1.40B |
| Operating income | $208.81M | -$68.71M | $7.32M | $172.69M | $202.92M |
| EBITDA | $275.16M | -$27.42M | $31.13M | $158.47M | $236.10M |
| Net income | $165.39M | -$99.07M | -$60.41M | $66.33M | $130.96M |
| EPS (diluted) | $1.94 | $-1.19 | $-0.73 | $1.58 | $3.06 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $2.25B | $2.15B | $2.22B | $2.35B | $2.72B |
| Total liabilities | $1.38B | $1.39B | $1.37B | $1.46B | $1.83B |
| Shareholders’ equity | $865.85M | $764.94M | $849.06M | $891.63M | $896.49M |
| Cash and equivalents | $375.24M | $229.94M | $73.26M | $9.82M | $387.39M |
| Long-term debt | $596.22M | $629.06M | $665.66M | $676.59M | $41.40M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $271.09M | $206.57M | $137.32M | $166.94M | $76.74M |
| Capital expenditure | -$18.46M | -$22.02M | -$33.33M | -$29.71M | -$32.25M |
| Free cash flow | $252.63M | $184.55M | $104.00M | $137.23M | $44.49M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MD | $26.25 | +1.6% | 132.51K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Pediatrix Medical Group, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW